The India-listed shares of Pfizer Limited have shown active momentum, closing at ₹4,874.80

The India-listed shares of Pfizer Limited have shown active momentum, closing at ₹4,874.80 on the National Stock Exchange. Positive sentiment spilled over from its global parent company, which raised its lower-end full-year 2026 revenue guidance to $60.5 billion–$62.5 billion. This update followed a strong quarterly earnings beat driven by non-COVID cancer and heart ***** and Corporate ActionsProduct Clarification: The Bombay Stock Exchange sought a formal clarification from Pfizer Limited regarding market news detailing the suspension of Premarin vaginal cream distribution in ***** Tax Assessment: The company reported receiving a fresh assessment order from the Assessment Unit of the Income-tax Department under Regulation 30 of the SEBI Listing Obligations and Disclosure ***** Transition: Chief Financial Officer and Executive Director Amit Agarwal tendered his resignation from the company, triggering a financial leadership transition phase.